Aura Biosciences, Inc.
AURA
$7.00
$0.142.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.57% | 1.06% | -24.18% | -32.86% | -39.47% |
| Total Depreciation and Amortization | -5.84% | -6.53% | -10.54% | -8.63% | -4.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.52% | 28.70% | 80.13% | 81.11% | 94.97% |
| Change in Net Operating Assets | -200.71% | 265.39% | -41.89% | 17.51% | 106.22% |
| Cash from Operations | -27.99% | 14.54% | -31.89% | -28.81% | 4.49% |
| Capital Expenditure | 45.45% | 41.14% | 86.80% | 92.57% | -112.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.33% | 0.02% | -529.85% | -1.72% | 216.32% |
| Cash from Investing | 84.14% | 0.43% | -545.13% | 0.69% | 217.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 84.38% | 409.58% | 509.36% | 55,946.99% | -62.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 212.50% | 409.58% | 509.36% | 84,151.81% | -62.06% |
| Foreign Exchange rate Adjustments | -28.57% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 286.93% | 90.30% | -1,181.36% | 1,721.42% | 144.13% |